Pediatric in-center hemodialysis patients

Slides:



Advertisements
Similar presentations
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 3: Clinical Indicators and Preventive Care.
Advertisements

Figure 3.1 ESRD clinical indicators, CROWNWeb data, December 2015
The Epidemiology of Hemoglobin Levels in Patients With Type 2 Diabetes
December 31st point prevalent counts by modality figure 3.1
Chapter 2: Clinical Indicators and Preventive Care
Renal Function Testing
Hemodialysis Vascular Access Creation in Patients Switching From Peritoneal Dialysis to Hemodialysis: A Population-Based Retrospective Cohort  Ahmed A.
Anemia management in chronic kidney disease
American Journal of Kidney Diseases 
ESRD Care Within the US Department of Veterans Affairs: A Forward-Looking Program With an Illuminating Past  Suzanne Watnick, MD, Susan T. Crowley, MD 
Spectrum and Burden of Erythropoiesis-Stimulating Agent Hyporesponsiveness Among Contemporary Hemodialysis Patients  Jiacong Luo, MD, MS, MPH, Donna E.
Douglas S. Fuller, MS, Ronald L. Pisoni, PhD, MS, Brian A
Peritoneal dialysis American Journal of Kidney Diseases
Quiz Page Answers December 2006
Hypertension in the hemodialysis patient and the “lag phenomenon”: insights into pathophysiology and clinical management  Uday M Khosla, MD, Richard J.
Volume 2: End-Stage Renal Disease
Dorian Schatell, MS, Meg Wise, PhD, Kristi Klicko, CHES, Bryan N
Edmund J. Bini, MD, MPH, Aditi Kinkhabwala, MD, David S. Goldfarb, MD 
Amir Said Alizadeh Naderi, MD, Biff F. Palmer, MD 
Clinical Practice Guidelines for Hemodialysis Adequacy, Update 2006
This Month in AJKD American Journal of Kidney Diseases
Dialysis Facility Ownership and Epoetin Dosing in Hemodialysis Patients: A Dialysis Provider’s Perspective  J. Michael Lazarus, MD, Raymond M. Hakim,
Solute-Solver: A Web-Based Tool for Modeling Urea Kinetics for a Broad Range of Hemodialysis Schedules in Multiple Patients  John T. Daugirdas, MD, Thomas.
Jan Havlin, MD, PhD, Karel Matousovic, DSc, Otto Schück, MD, DSc 
Mortality caused by sepsis in patients with end-stage renal disease compared with the general population  Mark J. Sarnak, Bertrand L. Jaber  Kidney International 
Volume 54, Issue 2, Pages (August 1998)
Erratum Regarding “Phosphate Removal With Several Thrice-Weekly Dialysis Methods in Overweight Hemodialysis Patients” [Am J Kidney Dis 2009; 54: ] 
The DOPPS Practice Monitor for US Dialysis Care: Update on Trends in Anemia Management 2 Years Into the Bundle  Douglas S. Fuller, MS, Ronald L. Pisoni,
Quiz Page December 2008 American Journal of Kidney Diseases
American Journal of Kidney Diseases
Hemoglobin Level and Transfusions in Patients on Maintenance Dialysis: Where the Rubber Meets the Road  Eduardo Lacson, MD, MPH, Franklin Maddux, MD 
Iain C. Macdougall, MD  American Journal of Kidney Diseases 
This Month in AJKD American Journal of Kidney Diseases
Factors Influencing Route of Administration for Epoetin Treatment Among Hemodialysis Patients in the United States  Mae Thamer, PhD, Yi Zhang, DDS, MS,
This Month in AJKD American Journal of Kidney Diseases
Routine Laboratory Testing Every 4 Versus Every 6 Weeks for Patients on Maintenance Hemodialysis: A Quality Improvement Project  Samuel A. Silver, Abdullah.
Quiz Page July 2012 American Journal of Kidney Diseases
Hypertension in the hemodialysis patient and the “lag phenomenon”: insights into pathophysiology and clinical management  Uday M Khosla, MD, Richard J.
Pharmacokinetics of Multiple-Dose Levofloxacin in Hemodialysis Patients  Shuichi Tsuruoka, MD, PhD, Noritsugu Yokota, MD, PhD, Tokie Hayasaka, RN, Tetsuo.
CPR 1.2.: Evaluation of Anemia in CKD
Quiz page December 2004 American Journal of Kidney Diseases
A Role for Bromine Deficiency in Sleep Disturbances of Long-Term Dialysis Patients  Caterina Canavese, MD, Ester De Costanzi, MD, Piero Stratta, MD, Enrico.
American Journal of Kidney Diseases
American Journal of Kidney Diseases
Study Designs in Patient-Oriented Research
Manish M. Tanna, MD, Edward F. Vonesh, PhD, Stephen M. Korbet, MD 
Erratum American Journal of Kidney Diseases
Quiz Page August 2007 American Journal of Kidney Diseases
Adult peritoneal dialysis patients
Making Music American Journal of Kidney Diseases
Differences in Blood Transfusion Trends Between US and UK Centers
Volume 64, Issue 3, Pages (September 2003)
This Month in AJKD American Journal of Kidney Diseases
Anemia After Renal Transplantation
Erratum American Journal of Kidney Diseases
The Use of Vaccines in Adult Patients With Renal Disease
August Heidland, MD, Udo Bahner, MD, Spiros Vamvakas, MD 
Volume 57, Issue 2, Pages (October 2000)
Anil K. Saxena, MD, B.R. Panhotra, MD, PhD, MNAMS 
Executive summary American Journal of Kidney Diseases
American Journal of Kidney Diseases
This Month in AJKD American Journal of Kidney Diseases
American Journal of Kidney Diseases
Increased Breast Calcifications in Women With ESRD on Dialysis: Implications for Breast Cancer Screening  Mario Castellanos, MD, Seema Varma, MD, Kathleen.
Serum Leptin and Epoetin Sensitivity
Clinical Practice Recommendations For Peritoneal Dialysis Adequacy
Stephen Pastan, J. Michael Soucie, William M. McClellan 
Clinical Practice Guidelines for Peritoneal Dialysis Adequacy
Quiz page December 2003 American Journal of Kidney Diseases
Results of a single center vascular screening and education program
Presentation transcript:

Pediatric in-center hemodialysis patients   American Journal of Kidney Diseases  Volume 44, Pages 44-52 (August 2004) DOI: 10.1053/j.ajkd.2004.05.009

Fig 56 Distribution of mean delivered calculated, single session spKt/V values for all pediatric (aged <18 years) in-center hemodialysis patients, by age group, October-December 2002. 2003 ESRD CPM Project. American Journal of Kidney Diseases 2004 44, 44-52DOI: (10.1053/j.ajkd.2004.05.009)

Fig 57 Percent of all pediatric (aged ≥12 to <18 years) male in-center hemodialysis patients with mean delivered calculated, single session spKt/V ≥1.2, by race, October-December 2002 compared to previous study periods. 2003 ESRD CPM Project. American Journal of Kidney Diseases 2004 44, 44-52DOI: (10.1053/j.ajkd.2004.05.009)

Fig 58 Percent of all pediatric (aged ≥12 to <18 years) female in-center hemodialysis patients with mean delivered calculated, single session spKt/V ≥1.2, by race, October-December 2002 compared to previous study periods. 2003 ESRD CPM Project. American Journal of Kidney Diseases 2004 44, 44-52DOI: (10.1053/j.ajkd.2004.05.009)

Fig 59 Distribution of mean delivered blood pump flow rates normalized for BSA 60 minutes into the dialysis session for all pediatric (aged <18 years) in-center hemodialysis patients by access type, October-December 2002. 2003 ESRD CPM Project. American Journal of Kidney Diseases 2004 44, 44-52DOI: (10.1053/j.ajkd.2004.05.009)

Fig 60 Vascular access type for pediatric (aged ≥12 to <18 years) in-center hemodialysis patients on their last hemodialysis session during the study period, October-December 2002 compared to previous study periods. 2003 ESRD CPM Project. American Journal of Kidney Diseases 2004 44, 44-52DOI: (10.1053/j.ajkd.2004.05.009)

Fig 61 Distribution of mean hemoglobin values (g/dL) for all pediatric (aged <18 years) in-center hemodialysis patients, by race, October-December 2002. 2003 ESRD CPM Project. American Journal of Kidney Diseases 2004 44, 44-52DOI: (10.1053/j.ajkd.2004.05.009)

Fig 62 Percent of all pediatric (aged <18 years) in-center hemodialysis patients with mean hemoglobin ≥11 g/dL, by selected patient characteristics and clinical parameters, October-December 2002. 2003 ESRD CPM Project. American Journal of Kidney Diseases 2004 44, 44-52DOI: (10.1053/j.ajkd.2004.05.009)

Fig 63 Percent of pediatric (aged ≥12 to <18 years) in-center hemodialysis patients with mean hemoglobin ≥11 g/dL, by gender, October-December 2002 compared to previous study periods. 2003 ESRD CPM Project. American Journal of Kidney Diseases 2004 44, 44-52DOI: (10.1053/j.ajkd.2004.05.009)

Fig 64 Percent of pediatric (aged ≥12 to <18 years) in-center hemodialysis patients with mean hemoglobin ≥11 g/dL, by race, October-December 2002 compared to previous study periods. 2003 ESRD CPM Project. American Journal of Kidney Diseases 2004 44, 44-52DOI: (10.1053/j.ajkd.2004.05.009)

Fig 65 Mean prescribed weekly IV Epoetin dose (units/kg/wk) for pediatric (aged ≥12 to <18 years) in-center hemodialysis patients, by hemoglobin category, October-December 2002 compared to previous study periods. 2003 ESRD CPM Project. American Journal of Kidney Diseases 2004 44, 44-52DOI: (10.1053/j.ajkd.2004.05.009)

Fig 66 Iron management parameters for pediatric (aged ≥12 to <18 years) in-center hemodialysis patients, October-December 2002 compared to previous study periods. 2003 ESRD CPM Project. American Journal of Kidney Diseases 2004 44, 44-52DOI: (10.1053/j.ajkd.2004.05.009)

Fig 67 Percent of all pediatric (aged <18 years) in-center hemodialysis patients with mean serum albumin ≥4.0/3.7 g/dL (BCG/BCP)^ and ≥3.5/3.2 g/dL (BCG/BCP), by age, October-December 2002. 2003 ESRD CPM Project. American Journal of Kidney Diseases 2004 44, 44-52DOI: (10.1053/j.ajkd.2004.05.009)

Fig 68 Percent of pediatric (aged ≥12 to <18 years) in-center hemodialysis patients with mean serum albumin ≥4.0/3.7 g/dL (BCG/BCP)∧ and ≥3.5/3.2 g/dL (BCG/BCP), October-December 2002 compared to previous study periods. 2003 ESRD CPM Project. American Journal of Kidney Diseases 2004 44, 44-52DOI: (10.1053/j.ajkd.2004.05.009)